Skip to main content

Table 1 Clinical characteristics and ECMO outcomes for critically ill COVID-19 patients (N = 12)

From: Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series

VariablesMean (SD)Rangen%
Age (years)50.9 (13.5)35–76  
Gender (male)  1191.7
 Hypertension  18.3
 Heart disease  18.3
 Diabetes  18.3
 Hyperthyroidism  18.3
Key reason for ICU admittance
 Dyspnea  1191.7
 Fever  1083.3
 Coma  18.3
Treatment type
 ECMO  12100
 Mechanical ventilation  12100
 Antibiotic treatment  12100
 Antiviral therapy  12100
 Glucocorticoid therapy  1083.3
 Supportive therapy based on symptoms  12100
Duration of ECMO use (days)11.3 (7.8)3–28  
ECMO prognosis
 Improving without ECMO  325.0
 Still alive with ECMO but two with coma  433.3
 Dying  541.7
  1. Abbreviations: ECMO extracorporeal membrane oxygenation, ICU intensive care unit